These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 9538270)

  • 1. Regio- and stereoselectivity in propranolol metabolism by dog liver microsomes and the expressed dog CYP2D15.
    Tasaki T; Iwata H; Kazusaka A; Fujita S
    J Biochem; 1998 Apr; 123(4):747-51. PubMed ID: 9538270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of human CYP isoforms involved in the metabolism of propranolol enantiomers--N-desisopropylation is mediated mainly by CYP1A2.
    Yoshimoto K; Echizen H; Chiba K; Tani M; Ishizaki T
    Br J Clin Pharmacol; 1995 Apr; 39(4):421-31. PubMed ID: 7640150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression and characterization of dog CYP2D15 using baculovirus expression system.
    Tasaki T; Nakamura A; Itoh S; Ohashi K; Yamamoto Y; Masuda M; Iwata H; Kazusaka A; Kamataki T; Fujita S
    J Biochem; 1998 Jan; 123(1):162-8. PubMed ID: 9504424
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Propranolol oxidation by human liver microsomes--the use of cumene hydroperoxide to probe isoenzyme specificity and regio- and stereoselectivity.
    Otton SV; Gillam EM; Lennard MS; Tucker GT; Woods HF
    Br J Clin Pharmacol; 1990 Nov; 30(5):751-60. PubMed ID: 2271375
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Species difference in enantioselectivity for the oxidation of propranolol by cytochrome P450 2D enzymes.
    Narimatsu S; Kobayashi N; Masubuchi Y; Horie T; Kakegawa T; Kobayashi H; Hardwick JP; Gonzalez FJ; Shimada N; Ohmori S; Kitada M; Asaoka K; Kataoka H; Yamamoto S; Satoh T
    Chem Biol Interact; 2000 Jun; 127(1):73-90. PubMed ID: 10903420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regio- and stereoselective propranolol metabolism by 15 forms of purified cytochromes P-450 from rat liver.
    Fujita S; Umeda S; Funae Y; Imaoka S; Abe H; Ishida R; Adachi T; Masuda M; Kazusaka A; Suzuki T
    J Pharmacol Exp Ther; 1993 Jan; 264(1):226-33. PubMed ID: 8423527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Substrate stereoselectivity and enantiomer/enantiomer interaction in propranolol metabolism in rat liver microsomes.
    Masubuchi Y; Yamamoto LA; Uesaka M; Fujita S; Narimatsu S; Suzuki T
    Biochem Pharmacol; 1993 Nov; 46(10):1759-65. PubMed ID: 8250961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Propranolol hydroxylation and N-desisopropylation by cytochrome P4502D6: studies using the yeast-expressed enzyme and NADPH/O2 and cumene hydroperoxide-supported reactions.
    Bichara N; Ching MS; Blake CL; Ghabrial H; Smallwood RA
    Drug Metab Dispos; 1996 Jan; 24(1):112-8. PubMed ID: 8825198
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytochrome P450 isozymes involved in propranolol metabolism in human liver microsomes. The role of CYP2D6 as ring-hydroxylase and CYP1A2 as N-desisopropylase.
    Masubuchi Y; Hosokawa S; Horie T; Suzuki T; Ohmori S; Kitada M; Narimatsu S
    Drug Metab Dispos; 1994; 22(6):909-15. PubMed ID: 7895609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression and characterization of canine cytochrome P450 2D15.
    Roussel F; Duignan DB; Lawton MP; Obach RS; Strick CA; Tweedie DJ
    Arch Biochem Biophys; 1998 Sep; 357(1):27-36. PubMed ID: 9721180
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxidation of (R)- and (S)-propranolol in human and dog liver microsomes. Species differences in stereoselectivity.
    von Bahr C; Hermansson J; Lind M
    J Pharmacol Exp Ther; 1982 Aug; 222(2):458-62. PubMed ID: 7097564
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regioselective contribution of the cytochrome P-450 2D subfamily to propranolol metabolism in rat liver microsomes.
    Masubuchi Y; Kagimoto N; Narimatsu S; Fujita S; Suzuki T
    Drug Metab Dispos; 1993; 21(6):1012-6. PubMed ID: 7905378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Substrate specificity and kinetic properties of seven heterologously expressed dog cytochromes p450.
    Shou M; Norcross R; Sandig G; Lu P; Li Y; Lin Y; Mei Q; Rodrigues AD; Rushmore TH
    Drug Metab Dispos; 2003 Sep; 31(9):1161-9. PubMed ID: 12920172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regio- and stereoselective oxidation of propranolol enantiomers by human CYP2D6, cynomolgus monkey CYP2D17 and marmoset CYP2D19.
    Narimatsu S; Nakata T; Shimizudani T; Nagaoka K; Nakura H; Masuda K; Katsu T; Koeda A; Naito S; Yamano S; Miyata A; Hanioka N
    Chem Biol Interact; 2011 Feb; 189(3):146-52. PubMed ID: 21184751
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glucuronidation of propranolol by dog liver microsomes. Effects of enantiomeric inhibition and detergent treatment on stereoselectivity.
    Wilson BK; Thompson JA
    Drug Metab Dispos; 1984; 12(2):161-4. PubMed ID: 6144480
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stereoselective metabolism of cibenzoline, an antiarrhythmic drug, by human and rat liver microsomes: possible involvement of CYP2D and CYP3A.
    Niwa T; Shiraga T; Mitani Y; Terakawa M; Tokuma Y; Kagayama A
    Drug Metab Dispos; 2000 Sep; 28(9):1128-34. PubMed ID: 10950860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytochrome P4502C9 is the principal catalyst of racemic acenocoumarol hydroxylation reactions in human liver microsomes.
    Thijssen HH; Flinois JP; Beaune PH
    Drug Metab Dispos; 2000 Nov; 28(11):1284-90. PubMed ID: 11038154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of CYP2C19 in stereoselective hydroxylation of mephobarbital by human liver microsomes.
    Kobayashi K; Kogo M; Tani M; Shimada N; Ishizaki T; Numazawa S; Yoshida T; Yamamoto T; Kuroiwa Y; Chiba K
    Drug Metab Dispos; 2001 Jan; 29(1):36-40. PubMed ID: 11124227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic kinetics of pseudoracemic propranolol in human liver microsomes. Enantioselectivity and quinidine inhibition.
    Marathe PH; Shen DD; Nelson WL
    Drug Metab Dispos; 1994; 22(2):237-47. PubMed ID: 8013280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prominent but reverse stereoselectivity in propranolol glucuronidation by human UDP-glucuronosyltransferases 1A9 and 1A10.
    Sten T; Qvisen S; Uutela P; Luukkanen L; Kostiainen R; Finel M
    Drug Metab Dispos; 2006 Sep; 34(9):1488-94. PubMed ID: 16763014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.